— Oversubscribed financing brings together leading syndicate of life sciences investors — — Proceeds to support clinical development of first-in-class therapies for neurological disorders – BOSTON, Oct. 30, 2024 /PRNewswire/ — Axonis Therapeutics, a biotechnology company focused on…
NEW YORK, Nov. 4, 2024 /PRNewswire/ — Evolution Equity Partners, is pleased to announce its investment in the Series B Round of Augment Inc., a pioneering AI coding assistance startup. Augment Inc. emerged from stealth earlier this…
Series B will enable Andium to scale its remote field monitoring platform, which already reduces operating costs by up to 45 percent and cuts greenhouse gas emissions by up to 65 percent for global energy…
MINNEAPOLIS, Oct. 28, 2024 /PRNewswire/ — Alimetry has raised an oversubscribed US $18m A2 financing round to commercialise its wearable gut health monitoring device, capitalizing on increased adoption by a growing cohort of US hospitals. This adoption is driven by Alimetry…
Investments will support new product offerings, US expansion, and development of pathology foundation models. BERLIN and NEW YORK, Oct. 29, 2024 /PRNewswire/ — Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights,…
New Funding Highlights Abstract’s Leadership in Building the Security Operations Platform of the Future PALO ALTO, Calif., Oct. 28, 2024 /PRNewswire/ — Abstract Security, a pioneer in security data fabric and analytics, announced today that it has closed…